Skip to main content
Equibles

GIKLY · Grifols SA

Track GIKLY — free

Use GIKLY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GIKLY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.55 At close · Oct 1
Rebalance outlook locked
Market Cap
$5.00B
Shares
680.58M
Volume · Oct 1 200 Avg daily vol (3 sessions) 967

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.55 Open$5.55 Day$5.55–5.55 52W close$5.06–6.85 Avg vol 30d1K Last earningsJul 28, 2026 DataFeb 2020–Oct 2026

Up next

Next earnings call
Oct 23, 2026 Est · unconfirmed · in 2 wks
Q1 2026 earnings call transcript
call held May 7, 2026

Guidance & track record

Latest guidance · from the Earnings Call filed Mar 31, 2026
Adjusted EBITDA margin · full year 2026 Non-GAAP Initiated at least 25%
Adjusted EBITDA growth · full year 2026 Non-GAAP Initiated 5% – 9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $6 › 200d $5 — 50d above 200d
Institutional flow Distributing
1 of 164 funds reported for Sep 30 · net -3.5K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
164 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $5 Now $6 · 27% Range high $7
vs 200-day avg +10% vs 50-day avg +0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - General — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GIKLY
Grifols SA
this stock
$5.00B — — — —
LLY
ELI LILLY & Co
 $1.11T +6.4% +44.7% 39.7 0.8%
JNJ
Johnson & Johnson
 $653.61B +22.2% +6.0% 31.5 0.9%
ABBV
AbbVie Inc.
 $466.80B +16.3% +8.6% 74.6 1.1%
MRK
Merck & Co., Inc.
 $367.07B +32.6% +1.3% 119.0 1.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
164
% held
21.0%
Reported
1 of 164
Top holder
BRANDES INVESTMENT PARTNE…
Held Float
View
Short & Settlement
Fails to Deliver
FTD shares
290
Value
$2.3K
As of
Sep 8, 2026
View
Smart Money
Congressional Trades Sell
Member
Daniel Goldman
Amount
$1.0K–$15.0K
Traded
Mar 31, 2023
View
Filings
SEC Filings
Latest
6-K
Filed
Jul 30, 2026
This year
12
View
Earnings & Events
Webcasts
Last webcast
Jul 28, 2026
View

Performance

5D 20D 120D MTD YTD
GIKLY -2.5% -7.7% +4.9% -3.5% -9.9%
SPY -0.4% -0.2% +12.4% +0.2% +12.0%
vs SPY -2.0% -7.5% -7.5% -3.7% -21.9%
Key facts CIK 1438569 CUSIP 398438408 Visit website Investor relations